Generated: 2026-09-29T23:04:17Z
> build_news_intel failed: BadRequestError
> Error code: 400 - {'type': 'error', 'error': {'type': 'invalid_request_error', 'message': 'Your credit balance is too low to access the Anthropic API. Please go to Plans & Billing to upgrade or purchase credits.'}, 'request_id': 'req_011CfYZppuaa85JtKzb7eEH4'}
Last 4 quarters EPS & revenue trajectory
| Metric | Current / TTM | YoY Change | Status |
|---|---|---|---|
| EPS (TTM) | $3.49 | −2.60% | Declining |
| Revenue Growth (YoY) | 6.48% | Moderate | Positive |
| Forward P/E | 32.75x | Compressed | Elevated |
| Trailing P/E | 53.26x | High | Premium |
Analysis: Revenue growth of 6.48% YoY shows resilience in the core software/supply chain optimization business. However, EPS contracted 2.6% YoY despite topline growth, signaling margin compression or increased cost burden. The substantial gap between trailing P/E (53.3x) and forward P/E (32.7x) implies market is pricing in material earnings recovery ahead—a bold assumption given current trajectory.
Margin structure and cash generation health
| Metric | Value | Assessment |
|---|---|---|
| Gross Margin | Data not disclosed | Coverage gap |
| Operating Margin | Data not disclosed | Coverage gap |
| Net Margin | Data not disclosed | Coverage gap |
| Free Cash Flow (TTM) | Data not disclosed | Coverage gap |
| ROE / ROIC | Data not disclosed | Coverage gap |
Analysis: Detailed profitability and cash flow metrics are not currently available through primary sources. However, the presence of flags for "high valuation" and "hyper growth" (despite negative EPS growth YoY) suggests the market is pricing MANH as a growth story rather than a current cash-generation powerhouse. The "strong profitability" flag is marked FALSE, indicating concerns around current margin health or return-on-capital efficiency.
Leverage, liquidity, and solvency position
| Metric | Value | Assessment |
|---|---|---|
| Cash & Equivalents | Data not disclosed | Coverage gap |
| Total Debt | Data not disclosed | Coverage gap |
| Net Debt / EBITDA | Data not disclosed | Coverage gap |
| Current Ratio | Data not disclosed | Coverage gap |
| Weak Balance Flag | FALSE | No red flag |
Analysis: Balance sheet detail is not available through current sources. However, the absence of a "weak balance" flag in system metrics suggests no immediate solvency or liquidity crisis. Beta of 0.93 (below market) implies lower leverage risk relative to sector, though this is inferential. Recommend obtaining latest 10-Q/10-K for detailed debt structure and covenant positions.
Absolute and relative valuation metrics
| Multiple | MANH | Interpretation |
|---|---|---|
| Trailing P/E | 53.26x | Extreme premium |
| Forward P/E | 32.75x | High premium |
| PEG Ratio | −20.49 | Negative (EPS declining) |
| EV / Enterprise Value | $11.7B | Implies large-cap premium valuation |
| Price / Sales | Data not disclosed | Unable to calculate |
| Price / FCF | Data not disclosed | Unable to calculate |
Analysis: MANH trades at a significant valuation premium: trailing P/E of 53.3x is extreme for a company with negative EPS growth. The 32.7x forward P/E implies the market is discounting a sharp earnings acceleration—likely 40%+ EPS growth over next 12–24 months. The negative PEG (−20.49) confirms this: with EPS declining, the valuation is divorced from fundamentals. High valuation flag is confirmed. Without comparables, cannot assess sector positioning, but these multiples are characteristic of "story stocks" expecting multi-year transformations.
Consensus view and price targets
| Metric | Value | Status |
|---|---|---|
| Consensus Rating | Data not disclosed | Coverage gap |
| Avg. Price Target | Data not disclosed | Coverage gap |
| High / Low Targets | Data not disclosed | Coverage gap |
| Implied Upside/Downside | Data not disclosed | Coverage gap |
| Target Dispersion | Data not disclosed | Coverage gap |
Analysis: Analyst consensus and price targets are not available through current sources. The data gap limits visibility into Wall Street sentiment shift. However, the 52-week performance (−8.75% YTD, down from $220.72 high) and recent −2.2% daily decline suggest sentiment may have soured post-earnings or macro shift. Recommend checking Bloomberg, Refinitiv, or company filings for latest institutional positioning.
Ownership, insider activity, and red flags
| Risk Factor | Status | Severity |
|---|---|---|
| Institutional Ownership Trend | Data not disclosed | Coverage gap |
| Insider Buying / Selling | Data not disclosed | Coverage gap |
| Short Interest | Data not disclosed | Coverage gap |
| High Valuation Flag | TRUE | Active |
| Hyper-Growth Flag | TRUE | Active |
| Strong Profitability Flag | FALSE | Warning |
| Weak Balance Flag | FALSE | Clear |
Analysis: System flags reveal core risk structure: MANH is tagged as "high valuation" + "hyper-growth" + "NOT strong profitability." This combination is dangerous—the stock is priced for aggressive growth but not delivering current profitability to justify the premium. Weak balance flag is absent, so balance sheet is not a near-term threat. However, the growth thesis is unproven (6.48% revenue growth is modest; EPS declining). Insider activity and short interest unknown but should be monitored as proxy for confidence levels.
Evidence base is incomplete due to data gaps, but available metrics paint a cautionary picture: premium valuation (P/E 53.3x trailing, 32.7x forward) combined with declining EPS growth and undisclosed profitability metrics creates significant execution risk. The "growth story" requires material earnings acceleration not yet visible in fundamentals.
MANH Stock Analysis & Forecast
Is MANH a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
MANH Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, MANH shows balanced risk-reward characteristics.
Should You Buy MANH Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in MANH.